2. Academic Validation
  3. The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer

The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer

  • Cytokine Growth Factor Rev. 2011 Feb;22(1):1-18. doi: 10.1016/j.cytogfr.2010.10.011.
Jo Vandercappellen 1,  Jo Van Damme,  Sofie Struyf
Affiliations

Affiliation

  • 1 Laboratory of Molecular Immunology, Rega Institute for Medical Research, University of Leuven (KULeuven), Minderbroedersstraat 10, B-3000 Leuven, Belgium.
PMID: 21111666 DOI: 10.1016/j.cytogfr.2010.10.011
Abstract

Chemokines are chemotactic cytokines which recruit leukocytes to inflammatory sites. They also affect tumor development and metastasis by acting as growth factor, by attracting pro- or anti-tumoral leukocytes or by influencing angiogenesis. Platelet factor-4 (CXCL4/PF-4) was the first chemokine shown to inhibit angiogenesis. CXCL4L1/PF-4var, recently isolated from thrombin-stimulated platelets, differing from authentic CXCL4/PF-4 in three carboxy-terminally located Amino acids, was found to be more potent than CXCL4/PF-4 in inhibiting angiogenesis and tumor growth. Both glycosaminoglycans (GAG) and CXCR3 are implicated in the activities of the PF-4 variants. This report reviews the current knowledge on the role of CXCL4/PF-4 and CXCL4L1/PF-4var in physiological and pathological processes. In particular, the role of CXCL4/PF-4 in Cancer, heparin-induced thrombocytopenia and atherosclerosis is described.

Figures
Products